Healthcare -
Biotechnology - NASDAQ - US
$ 30.91
-1.4 %
$ 2.01 B
Market Cap
-10.37
P/E
KYMR - ACCOUNTS PAYABLE
Accounts Payable KYMR - Kymera Therapeutics, Inc.
7.08 M
LAST VALUE
32.91%
2 YEAR CAGR
28.04%
5 YEAR CAGR
0.00%
10 YEAR CAGR